Identifying in vivo inflammation using magnetic nanoparticle spectra

Luminol-conjugated cyclodextrin biological nanoparticles for the treatment of severe burn-induced intestinal barrier disruption

Background

The breakdown of intestinal barrier integrity occurs after severe burn injury and is responsible for the subsequent reactions of inflammation and oxidative stress. A new protective strategy for the intestinal barrier is urgently needed due to the limitations of the traditional methods. Recently, the application of nanoparticles has become one of the promising therapies for many inflammation-related diseases or oxidative damage. Herein, we developed a new anti-inflammatory and antioxidant nanoparticle named luminol-conjugated cyclodextrin (LCD) and aimed to evaluate its protective effects in severe burn-induced intestinal injury.

Methods

First, LCD nanoparticles, engineered with covalent conjugation between luminol and β-cyclodextrin (β-CD), were synthesized and examined. Then a mouse burn model was successfully established before the mouse body weight, intestinal histopathological manifestation, permeability, tight junction (TJ) expression and pro-inflammatory cytokines were determined in different groups. The proliferation, apoptosis, migration and reactive oxygen species (ROS) of intestinal epithelial cells (IECs) were assessed. Intraepithelial lymphocytes (IELs) were isolated and cultured for analysis by flow cytometry.

Results

LCD nanoparticle treatment significantly relieved the symptoms of burn-induced intestinal injury in the mouse model, including body weight loss and intestinal permeability abnormalities. Moreover, LCD nanoparticles remarkably recovered the mechanical barrier of the intestine after severe burn, renewed TJ structures, promoted IEC proliferation and migration, and inhibited IEC apoptosis. Mechanistically, LCD nanoparticles dramatically alleviated pro-inflammation factors (tumor necrosis factor-α, IL-17A) and ROS accumulation, which could be highly involved in intestinal barrier disruption. Furthermore, an increase in IL-17A and the proportion of IL-17A+Vγ4+ γδ T subtype cells was also observed in vitro in LPS-treated Vγ4+ γδ T cells, but the use of LCD nanoparticles suppressed this increase.

Conclusions

Taken together, these findings demonstrate that LCD nanoparticles have the protective ability to ameliorate intestinal barrier disruption and provide a therapeutic intervention for burn-induced intestinal injury.

Magnetic Particle Spectroscopy for Point-of-Care: A Review on Recent Advances

Since its first report in 2006, magnetic particle spectroscopy (MPS)-based biosensors have flourished over the past decade. Currently, MPS are used for a wide range of applications, such as disease diagnosis, foodborne pathogen detection, etc. In this work, different MPS platforms, such as dual-frequency and mono-frequency driving field designs, were reviewed. MPS combined with multi-functional magnetic nanoparticles (MNPs) have been extensively reported as a versatile platform for the detection of a long list of biomarkers. The surface-functionalized MNPs serve as nanoprobes that specifically bind and label target analytes from liquid samples. Herein, an analysis of the theories and mechanisms that underlie different MPS platforms, which enable the implementation of bioassays based on either volume or surface, was carried out. Furthermore, this review draws attention to some significant MPS platform applications in the biomedical and biological fields. In recent years, different kinds of MPS point-of-care (POC) devices have been reported independently by several groups in the world. Due to the high detection sensitivity, simple assay procedures and low cost per run, the MPS POC devices are expected to become more widespread in the future. In addition, the growth of telemedicine and remote monitoring has created a greater demand for POC devices, as patients are able to receive health assessments and obtain results from the comfort of their own homes. At the end of this review, we comment on the opportunities and challenges for POC devices as well as MPS devices regarding the intensely growing demand for rapid, affordable, high-sensitivity and user-friendly devices.

Magnetic nanoparticles and magnetic particle spectroscopy-based bioassays: a 15 year recap

Magnetic nanoparticles (MNPs) have unique physical and chemical properties, such as high surface area to volume ratio and size-related magnetism, which are completely different from their bulk materials. Benefiting from the facile synthesis and chemical modification strategies, MNPs have been widely studied for applications in nanomedicine. Herein, we firstly summarized the designs of MNPs from the perspectives of materials and physicochemical properties tailored for biomedical applications. Magnetic particle spectroscopy (MPS), first reported in 2006, has flourished as an independent platform for many biological and biomedical applications. It has been extensively reported as a versatile platform for a variety of bioassays along with the artificially designed MNPs, where the MNPs serve as magnetic nanoprobes to specifically probe target analytes from fluid samples. In this review, the mechanisms and theories of different MPS platforms realizing volumetric- and surface-based bioassays are discussed. Some representative works of MPS platforms for applications such as disease diagnosis, food safety and plant pathology monitoring, drug screening, thrombus maturity assessments are reviewed. At the end of this review, we commented on the rapid growth and booming of MPS-based bioassays in its first 15 years. We also prospected opportunities and challenges that portable MPS devices face in the rapidly growing demand for fast, inexpensive, and easy-to-use biometric techniques.

The biological effects of geomagnetic field exhibit an important potential for cancer and vascular diseases

Xu et al. recently demonstrated that cryptochrome 4 (CRY4) protein, as a light-dependent magnetic receptor, can sense geomagnetic fields to guide night-migratory songbirds' navigation and evolution by the formation of composite radical pairs and electron transport. We aim to comment on CRY4 through radical pairs and electron transport for magnetic sensitive in night-migratory songbirds' migration and evolution. Additionally, we find that the role of magnetic fields is deeply concerning to the scientific community and very enlightening for the diagnosis and treatment of cancer and vascular disease. We believe that this commentary makes a significant contribution to the literature because it elaborates on the importance of the geomagnetic field to night-migratory songbirds and extends the diagnostic and therapeutic value to cancer and vascular disease. This article is protected by copyright. All rights reserved.

Simultaneous temperature and viscosity estimation capability via magnetic nanoparticle relaxation

PURPOSE

Magnetic particle imaging (MPI) is emerging as a highly promising imaging modality. Magnetic nanoparticles (MNPs) are used as imaging tracers in MPI, and their relaxation behavior provides the foundation for its functional imaging capability. Since MNPs are also utilized in magnetic fluid hyperthermia (MFH) and MPI enables localized MFH, temperature mapping arises as an important application area of MPI. To achieve accurate temperature estimations, however, one must also take into account the confounding effects of viscosity on the MPI signal. In this work, we analyze the effects of temperature and viscosity on MNP relaxation, and determine temperature and viscosity sensitivities of relaxation time constant estimations via TAURUS (TAU estimation via Recovery of Underlying mirror Symmetry) at a wide range of operating points to empower simultaneous mapping of these two parameters.

METHODS

A total of 15 samples were prepared to reach 4 target viscosity levels (0.9-3.6 mPa·s) at 5 different temperatures (25-45°C). Experiments were performed on a magnetic particle spectrometer (MPS) setup at 60 different operating points at drive field amplitudes ranging between 5-25 mT and frequencies ranging between 1-7 kHz. To enable these extensive experiments, an in-house arbitrary-waveform MPS setup with temperature-controlled heating capability was developed. The operating points were divided into 4 groups with comparable signal levels to maximize signal gain during rapid signal acquisition. The relaxation time constants were estimated via TAURUS, by restoring the underlying mirror symmetry property of the positive and negative half cycles of the time-domain MNP response. The relative time constants with respect to the drive field period, τ̂, were computed to enable quantitative comparison across different operating points. At each operating point, a linear fit was performed to τ̂ as a function of each functional parameter (i.e., temperature or viscosity). The slopes of these linear fits were utilized to compute the temperature and viscosity sensitivities of TAURUS.

RESULTS

Except for outlier behaviors at 1 kHz, the following global trends were observed: τ̂ decreases with drive field amplitude, increases with drive field frequency, decreases with temperature, and increases with viscosity. The temperature sensitivity varies slowly across the operating points and reaches a maximum value of 1.18%/°C. In contrast, viscosity sensitivity is high at low frequencies around 1 kHz with a maximum value of 13.4%/(mPa·s), but rapidly falls down after 3 kHz. These results suggest that the simultaneous estimation of temperature and viscosity can be achieved by performing measurements at two different drive field settings that provide complementary temperature/viscosity sensitivities. Alternatively, temperature estimation alone can be achieved with a single measurement at drive field frequencies above 3 kHz, where viscosity sensitivity is minimized.

CONCLUSIONS

This work demonstrates highly promising temperature and viscosity sensitivities for TAURUS, highlighting its potential for simultaneous estimation of these two environmental parameters via MNP relaxation. The findings of this work reveal the potential of a hybrid MPI-MFH system for real-time monitored and localized thermal ablation treatment of cancer. This article is protected by copyright. All rights reserved.